Consider participating in a clinical research study to evaluate the effectiveness and safety of an oral study drug that may help slow the progression of mild to moderate Alzheimer’s disease.
To participate, you must be 55 to 85 years old with symptoms of mental or functional decline dating back at least a year. Your partner or caregiver must be willing to bring you to study visits. Other eligibility criteria apply.
Study-related drugs and care will be provided at no cost.
For more information about the potential benefits and risks of the study, please contact Natalie Stone, MS, CCRC:
Holston Medical Group’s clinical research department (HMG CR) has been impacting lives through the conduct of clinical studies since 1996. HMG CR has conducted over 800 phase II-IV pediatric and adult clinical trials with it’s physician investigators having extensive experience in many disease states and conditions. HMG CR conducts between 80 to 100 clinical trials annually with over 20 primary and sub-investigators. HMG CR is nationally recognized for its outstanding achievements in the field of clinical research.
Have a question or comment for HMG Clinical Research?
Please contact us with your questions or comments. We look forward to hearing from you.